Pre-Annual General Meeting Information • Mar 31, 2022
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action you should take, you are recommended to seek your own personal financial advice from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser (who in the United Kingdom should be authorised under the Financial Services and Markets Act 2000).
If you have sold or otherwise transferred all your holding of Ordinary Shares in HICL Infrastructure PLC, please send this document, together with the attached Form of Proxy, as soon as possible, to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for delivery to the purchaser or transferee. If you have sold any part of your holding of Ordinary Shares in HICL Infrastructure PLC, please contact your stockbroker, bank or other agent through whom the sale or transfer was effected immediately.
(incorporated in England and Wales under the Companies Act 2006 with registered no. 11738373 and registered as an investment company under section 833 of the Companies Act 2006)
Circular to Shareholders
-and-
Notice of Extraordinary General Meeting
This document should be read as a whole. Your attention is drawn to the letter from your Chairman which is set out on pages 2 to 4 of this document and which recommends that you vote in favour of the resolution to be proposed at the Extraordinary General Meeting to be held at 9.30a.m. on 28 April 2022.
Your attention is also drawn to the Notice of Extraordinary General Meeting which is set out on pages 5 to 7 of this document.
Proxy Forms for the Extraordinary General Meeting must be received by the Company's Receiving Agent and UK Transfer Agent, Link Group, PXS 1, Central Square, 29 Wellington Street, Leeds, LS1 4DL by no later than 9:30a.m. on 26 April 2022.
The Company is a UK domiciled investment company under section 833 of the Companies Act 2006.
(incorporated in England and Wales under the Companies Act 2006 with registered no. 11738373 and registered as an investment company under section 833 of the Companies Act 2006)
Susanna Frances Davies Sally-Ann Farnon Simon Holden Frank Nelson Kenneth Reid
Directors Registered Office: Ian Russell (Chairman) Level 7, One Bartholomew Close Rita Akushie Barts Square Michael Bane London, EC1A 7BL
31 March 2022
To holders of Ordinary Shares in HICL Infrastructure PLC ("HICL" or the "Company") ("Shareholders")
Dear Shareholder,
I am writing to you with details of a proposed disposal of the Company's investment in the Queen Alexandra Hospital PFI Project ("QAH", or the "Investment") to InfraRed European Infrastructure Income Fund 4 ("EIIF4", or the "Purchaser") (the "Disposal").
The Board is seeking the approval of Shareholders for the proposed Disposal, as the Purchaser is a fund managed by InfraRed Capital Partners Limited ("InfraRed", or the "Investment Manager"), the Company's investment manager. The Disposal is not a related party transaction for the purposes of the Listing Rules, however the Board is asking Shareholders to approve the Disposal as a matter of good corporate governance.
The Board is convening an extraordinary general meeting (the "EGM") at 9.30a.m. on 28 April 2022, in order to put an ordinary resolution approving the Disposal to Shareholders (the "Resolution"). The purpose of this Circular is to explain to Shareholders the background to, and reasons for, the Disposal. Notice of the EGM and the Form of Proxy are set out at the end of this Circular.
Following a competitive auction process, which saw several bids for the Investment from a range of buyers who were unconnected to the Investment Manager, the Board is pleased to announce that HICL has conditionally agreed to dispose of its 100% interest in QAH to EIIF 4. This disposal is in line with the Company's stated strategy to deliver shareholder value and optimise portfolio composition through periodic disposals. The transaction is accretive to key portfolio metrics.
Proceeds to HICL will be c. £108m, with profits from the sale representing a 1.5 pence per share increase on NAV relative to HICL's valuation at 30 September 2021. Proceeds from the disposal will be redeployed into HICL's advanced pipeline, as well as used to pay down the Company's revolving credit facility.
HICL invested in QAH in 2010. QAH is a flagship, acute public hospital with over 7,200 staff and 1,200 beds, that serves over 675,000 residents across Portsmouth and south-east Hampshire. QAH was built and then managed by Carillion plc. Following the liquidation of Carillion plc in 2018, HICL, via the Investment Manager, assumed responsibility for the construction and facility management risk associated with the project. Between 2018 and 2021, InfraRed transitioned QAH to a new facilities management provider, EQUANS, and finalised the resolution of all the outstanding contractual obligations with the client, the project's lenders and EQUANS. By working collaboratively with all the key project stakeholders, the Investment Manager was able to successfully stabilise the project. InfraRed's active asset management strategy for QAH over the last four years is a key contributor to the uplift in NAV per share recognised on disposal.
In addition to running a competitive auction with third party bidders, the Company and its Investment Manager implemented certain "Rules of Engagement" to manage the potential conflicts of interest. These are further detailed below.
Under the terms of a sale and purchase agreement dated 30 March 2022, (the "SPA"), the Company has agreed to sell the Company's entire interest in the Investment, for an aggregate consideration of c. £108m. Completion of the SPA is conditional on approval of the Resolution at the EGM. Assuming that the Resolution is passed at the EGM, completion of the Disposal is expected to occur in May 2022.
The Disposal is on terms that the Company has been advised are market standard.
To manage conflicts of interest, the Company and its Investment Manager implemented the "Rules of Engagement", as detailed in the Company's 2019 Prospectus. These detailed procedures have been established to manage transactions between the Company, the Investment Manager and funds managed by the Investment Manager. The Board has ensured that these procedures have been adopted in connection with the proposed disposal. In particular:
The Investment Manager established a "buyside" committee (acting for the Purchaser) and a "sellside" committee (acting for the Company) to consider the terms of the Disposal and information barriers were put in place between each committee.
The "sellside" committee, which included an independent non-executive Director of the Company, oversaw the auction process and determined that the Purchaser had the most competitive bid. The Company has the benefit of the existing independent valuation of the Investment as at 30 September 2021, and the agreed consideration is in excess of that.
The Board has had the opportunity to ask questions of the "sellside" committee and to review the proposed terms of the Disposal prior to the terms of the Disposal being agreed, to ensure that it is satisfied that they have been negotiated on an arm's length basis. Furthermore, the Board is comfortable that the price negotiated for the Disposal is in line with market pricing for a stable flagship acute hospital more generally.
You will find enclosed a Form of Proxy. You are invited to complete and return the Form of Proxy as soon as possible in accordance with the written instructions. The Form of Proxy should be lodged with the Company's Receiving Agent and UK Transfer Agent, Link Group, PXS 1, Central Square, 29 Wellington Street, Leeds, LS1 4DL, so as to be received not later than 9:30a.m. (UK Time) on 26 April 2022. Shareholders may appoint more than one proxy provided that each proxy is appointed to exercise rights attaching to different Ordinary Shares. Any proxy need not be a member of the Company. Shareholders are strongly encouraged to appoint the Chairman of the Meeting as their proxy.
The Board believes that the Disposal of the Investment is in the best interests of the Company and Shareholders as a whole and unanimously recommends that Shareholders vote in favour of the Resolution, as all of the Directors intend to do in respect of their own beneficial holdings of Ordinary Shares which amount in aggregate to 506,688 Ordinary Shares (representing approximately 0.3 per cent. of the existing issued ordinary share capital of the Company).
Yours faithfully,
Ian Russell CBE Chairman
(incorporated in England and Wales under the Companies Act 2006 with registered no. 11738373 and registered as an investment company under section 833 of the Companies Act 2006)
NOTICE IS HEREBY GIVEN that an EXTRAORDINARY GENERAL MEETING (the "EGM") of HICL Infrastructure PLC (the "Company") will be held at Atlantic House, Holborn Viaduct, London EC1A 2FG at 9.30a.m. on 28 April 2022. Defined terms in this notice will have the meaning given to them in the circular published on 31 March 2022 (the "Circular"). This EGM is being convened for the purpose of considering and, if thought fit, passing the following Resolution, which will be proposed as an ordinary resolution:
THAT, the proposed Disposal by the Company of the Queen Alexandra Hospital PFI Project on such terms as may be agreed by the Company and InfraRed European Infrastructure Income Fund 4, subject to all other actions necessary to effect the Disposal, be and is hereby approved.
By order of the board
31 March 2022
Registered Office
Level 7, One Bartholomew Close Barts Square London, EC1A 7BL
Proxymity will then contract with your underlying institutional account holder directly to accept their vote instructions through the platform.
Shareholders who have questions relating directly to the business of the EGM should forward their questions in advance to the Company Secretary by email to [email protected] by no later than 4:00p.m. on 27 April 2022.
incorporated in England and Wales under the Companies Act 2006 with registered no. 11738373 and registered as an investment company under section 833 of the Companies Act 2006
FORM OF PROXY for use by shareholders at the Extraordinary General meeting ("EGM") of HICL Infrastructure PLC (the "Company") to be held at Atlantic House, Holborn Viaduct, London EC1A 2FG at 09:30 AM on Thursday, 28 April 2022 to consider and, if thought fit, pass the following resolution.
I/We,
................................................................................................ (complete in block capitals)
In the case of joint shareholders, the names of all joint holders should be shown
of,
................................................................................................
................................................................................................
(complete in block capitals)
member/members of the Company, hereby appoint the Chairman of the meeting (refer to Note 2)
or, failing him,
| ADDRESS OF PROXY | (complete in block capitals) |
|
|---|---|---|
| TICK THIS BOX IF THIS PROXY APPOINTMENT IS ONE OF MULTIPLE APPOINTMENTS |
(complete in block capitals) For the appointment of more than one proxy, please refer to note 3. |
|
| NUMBER OF SHARES TO WHICH THIS PROXY RELATES |
||
Note: Leave blank if you are only appointing one proxy in respect of all your shares. |
as my/our proxy to attend, speak, and vote in my/our names(s) and on my/our behalf at the 2022 EGM and at any adjournment thereof.
I/We wish my/our proxy to vote as indicated below in respect of the ordinary resolution to be proposed at the meeting. Please indicate which way you wish your proxy to vote by ticking the appropriate box alongside the resolution and then proceed to Step 2 to sign and date the declaration. (Refer to Note 4)
The 'vote withheld' option is provided to enable you to direct your proxy to abstain on any resolution. If a vote is withheld it will not be counted in the calculation of the proportion of votes for or against the relevant resolution.
| FOR | AGAINST | VOTE WITHELD |
|
|---|---|---|---|
| ORDINARY BUSINESS | |||
| Ordinary Resolution | |||
| THAT, the proposed Disposal by the Company of the Queen Alexandra Hospital PFI Project on such terms as may be agreed by the Company and InfraRed European Infrastructure Income Fund 4, subject to all other actions necessary to effect the Disposal, be and is hereby approved. |
Signature: ____________________________________________
Date: ____________________
Print Name: ____________________________________________
CREST members who wish to appoint a proxy or proxies by utilising the CREST electronic proxy appointment service may do so for the 2022 EGM and any adjournment(s) thereof by utilising the procedures described in the CREST Manual available on the website of Euroclear UK and Ireland Limited ("Euroclear") at www.euroclear.com. CREST Personal Members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.
In order for a proxy appointment made by means of CREST to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with Euroclear's specifications and must contain the information required for such instructions, as described in the CREST Manual. The message must be transmitted so as to be received by the issuer's agent (RA10) by the latest time(s) for receipt of proxy appointments specified in the notice of meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.
CREST members and, where applicable, their CREST sponsors or voting service providers should note that Euroclear does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.
For further information, please contact the Company Secretary, Aztec Financial Services (UK) Limited by telephone on +44 (0) 23 8202 2300 or by email at [email protected].
Capitalised terms used in this form of proxy shall, unless the context otherwise requires, have the meaning given to them in the notice of the 2022 EGM dated 31 March 2022 (the "EGM Circular").
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.